Trouble in Your Tank: Causes of Plating Voids, Pre-electroless Copper
Dan’s Biz Bookshelf: ‘Growth Hacker Marketing’
Happy’s Tech Talk #38: Novel Metallization for UHDI
Audiology Devices Market Worth $15.5 Billion by 2026
July 15, 2019 | Grand View Research, Inc.Estimated reading time: 1 minute
The global audiology devices market size is expected to reach $15.5 billion by 2026 registering a CAGR of 5.8%, according to a new report by Grand View Research, Inc. Increasing cases of hearing disorders, especially in geriatric population, rising purchasing capacity, investments in R&D, and government support for better healthcare infrastructure are expected to drive the market over the forecast period.
High comfort offered by newly introduced devices, improved connectivity, and better user interface are some of the factors attributing to high usage rate of audiology devices. Better quality of life along with acceptance of digital hearing aids are anticipated to further drive the market. In a study published in January 2019, it was observed that hearing aids reduce symptoms associated with dementia. However, usage is hampered due to the exclusion of hearing aids or exams for fitting hearing aids from the Original Medicare program.
Hearing aids segment led the market in 2018 and will hold its leading position in future. However, cochlear implants is expected to be the fastest-growing segment over the forecast period. Cochlear implants are widely used owing to their high effectiveness, in terms of sentence understanding.
Further key findings from the study suggest:
-
Digital hearing aids led the technology segment in terms of market share in 2018 due to their increased adaptability and connectivity with mobile devices
-
Retail sales channel was the dominant segment in 2018 and is projected to expand further at the fastest CAGR during the forecast period
-
North America dominated the global audiology devices market in 2018 due to technological advancements and presence of major market participants in the region
-
Asia Pacific is anticipated to witness the fastest CAGR owing to improving healthcare infrastructure along with growing geriatric population in emerging countries, such as India and China
-
Key industry participants include GN ReSound Group;William Demant Holdings A/S; Starkey Hearing Technologies; Widex A/S; Sonova Holdings AG; Phonak, Audioscan; MedRx; Austar Hearing; National Hearing Care; and NHC/Amplifon
Share on:
Suggested Items
DELO Thrives Amid Global Economic Uncertainty
05/09/2025 | DELOGermany/Sudbury, MA, May 9, 2025 | DELO, one of the world’s leading manufacturers of high-tech adhesives as well as dispensing and curing equipment, has announced that it has achieved over €245 million ($265 million) in revenue during the 2024/2025 fiscal year (ending March 31, 2025).
AI Chips for the Data Center and Cloud Market Will Exceed US$400 Billion by 2030
05/09/2025 | IDTechExBy 2030, the new report "AI Chips for Data Centers and Cloud 2025-2035: Technologies, Market, Forecasts" from market intelligence firm IDTechEx forecasts that the deployment of AI data centers, commercialization of AI, and the increasing performance requirements from large AI models will perpetuate the already soaring market size of AI chips to over US$400 billion.
Imec Coordinates EU Chips Design Platform
05/09/2025 | ImecA consortium of 12 European partners, coordinated by imec, has been selected in the framework of the European Chips Act to develop the EU Chips Design Platform.
Creative Electron Strengthens Leadership Team with Strategic Appointments in Marketing and SMT Business Unit
05/08/2025 | Creative ElectronCreative Electron, the largest U.S. manufacturer of X-ray inspection systems for the electronics industry, is proud to announce the addition of two seasoned leaders to its executive team: Wagner Lima as Marketing Director and Giancarlo De La Garza as SMT Business Unit Director.
Kyocera Licenses Quadric’s Chimera GPNPU AI Processor IP
05/08/2025 | BUSINESS WIREQuadric announced that Kyocera Document Solutions Inc. (hereinafter: Kyocera) has licensed the Chimera™ general purpose neural processor (GPNPU) intellectual property (IP) core for use in next generation office automation system on-chip (SoC) designs.